Posted on 14/09/2013
Dr Jackie Hunter CBE
BSc Physiology & Psychology, 1977; PhD Psychology, 1981 Bedford College
Jackie is a leading scientist and bioscience innovator, who was Senior VP and Head of Science Environment Development at GlaxoSmithKline. She is now CEO of BenevolentBIo, the bioscience arm of BenevolentAI as well as a Director of BenevolentAI. Hunter is also a non-Executive Director of Chiltern International Group, a global CRO. Jackie Hunter is also a Professor at St George's Hospital Medical School and was CEO of the Biotechnology and Biological Sciences Research Council. At Glaxo she developed new ways to work with academia and other publically funded bodies. She also helped drive forward the Innovative Medicines Initiative for Europe as an IMI Board member. Prior to 2008, she was Head of the Neurology Centre of Excellence for Drug Discovery at GlaxoSmithKline and led the discovery and development of new therapeutics for neurological and gastrointestinal disorders. For most of her industrial career she has focused on the discovery of drugs for serious neurological diseases such as Parkinson's disease. Her main research areas are stroke and Alzheimer's Disease and she has played a major role in initiating and organising international meetings on these topics. She has also been associated with the development of drugs for the treatment of epilepsy and migraine. Jackie is now a member of our College Council.